Stephan Becker, PhD, is Professor of Virology and Director of the Institute of Virology at Philipps University Marburg. His research focuses on emerging viruses such as the Ebola virus, the Marburg virus and the MERS coronavirus. In addition to basic research on the biology and pathogenesis of the aforementioned viruses, his laboratory is involved in translational research to develop antivirals and vaccines against emerging viruses, from early preclinical steps to immune monitoring in clinical trials. In 2014/2015, his laboratory supported the four phase 1 clinical trials of the VSV-ZEBOV vaccine as part of the WHO-led VEBCON consortium. He is a Fellow of the National Academy Leopoldina and Deputy Spokesperson of the Emerging Infections Section at the German Center for Infection Research (DZIF, www.dzif.de/en). Stephan Becker coordinates a Collaborative Research Center funded by the German Research Foundation and a government-funded Center for the Identification of Targets to Combat Neglected Tropical Diseases. His publications have been cited over 25,000 times.
